These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1280411)

  • 1. Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study.
    Cosgrove DM; Heric B; Lytle BW; Taylor PC; Novoa R; Golding LA; Stewart RW; McCarthy PM; Loop FD
    Ann Thorac Surg; 1992 Dec; 54(6):1031-6; discussion 1036-8. PubMed ID: 1280411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting.
    Levy JH; Pifarre R; Schaff HV; Horrow JC; Albus R; Spiess B; Rosengart TK; Murray J; Clark RE; Smith P
    Circulation; 1995 Oct; 92(8):2236-44. PubMed ID: 7554207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of aprotinin on early graft thrombosis in patients undergoing myocardial revascularization.
    Kalangos A; Tayyareci G; Prêtre R; Di Dio P; Sezerman O
    Eur J Cardiothorac Surg; 1994; 8(12):651-6. PubMed ID: 7535064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. A multicenter, randomized, double-blind, placebo-controlled study.
    Lemmer JH; Stanford W; Bonney SL; Breen JF; Chomka EV; Eldredge WJ; Holt WW; Karp RB; Laub GW; Lipton MJ
    J Thorac Cardiovasc Surg; 1994 Feb; 107(2):543-51; discussion 551-3. PubMed ID: 7508070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations.
    Murkin JM; Lux J; Shannon NA; Guiraudon GM; Menkis AH; McKenzie FN; Novick RJ
    J Thorac Cardiovasc Surg; 1994 Feb; 107(2):554-61. PubMed ID: 7508071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting.
    Poston RS; White C; Gu J; Brown J; Gammie J; Pierson RN; Lee A; Connerney I; Avari T; Christenson R; Tandry U; Griffith BP
    Ann Thorac Surg; 2006 Jan; 81(1):104-10; discussion 110-1. PubMed ID: 16368345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant aprotinin in coronary artery bypass graft operations.
    Green D; Sanders J; Eiken M; Wong CA; Frederiksen J; Joob A; Palmer A; Trowbridge A; Woodruff B; Moerch M
    J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 1):963-70. PubMed ID: 7475162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aprotinin in primary valve replacement and reconstruction: a multicenter, double-blind, placebo-controlled trial.
    D'Ambra MN; Akins CW; Blackstone EH; Bonney SL; Cohn LH; Cosgrove DM; Levy JH; Lynch KE; Maddi R
    J Thorac Cardiovasc Surg; 1996 Oct; 112(4):1081-9. PubMed ID: 8873736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, placebo-controlled, double-blind study of an ultra-low-dose aprotinin regimen in reoperative and/or complex cardiac operations.
    Hardy JF; Bélisle S; Couturier A; Robitaille D
    J Card Surg; 1997; 12(1):15-22. PubMed ID: 9169364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aprotinin decreases exposure to allogeneic blood during primary unilateral total hip replacement.
    Murkin JM; Haig GM; Beer KJ; Cicutti N; McCutchen J; Comunale ME; Hall R; Ruzicka BB
    J Bone Joint Surg Am; 2000 May; 82(5):675-84. PubMed ID: 10819278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
    Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two doses of aprotinin in patients receiving aspirin before coronary bypass surgery.
    Moran SV; Lema G; Medel J; Irarrazaval MJ; Zalaquett R; Garayar B; Flaskamp R
    Perfusion; 2000 Mar; 15(2):105-10. PubMed ID: 10789564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aprotinin counterbalances an increased risk of peri-operative hemorrhage in CABG patients pre-treated with Aspirin.
    Klein M; Keith PR; Dauben HP; Schulte HD; Beckmann H; Mayer G; Elert O; Gams E
    Eur J Cardiothorac Surg; 1998 Oct; 14(4):360-6. PubMed ID: 9845139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aprotinin reduces postoperative bleeding and the need for blood products in thoracic surgery: results of a randomized double-blind study.
    Bedirhan MA; Turna A; Yagan N; Taşçi O
    Eur J Cardiothorac Surg; 2001 Dec; 20(6):1122-7. PubMed ID: 11717015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose aprotinin in cardiac operations.
    Haddad R; Kesrouani C; Nasr W
    J Med Liban; 2000; 48(3):157-60. PubMed ID: 11268570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group.
    Porte RJ; Molenaar IQ; Begliomini B; Groenland TH; Januszkiewicz A; Lindgren L; Palareti G; Hermans J; Terpstra OT
    Lancet; 2000 Apr; 355(9212):1303-9. PubMed ID: 10776742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aprotinin (Trasylol) on aorta-coronary bypass graft patency.
    Bidstrup BP; Underwood SR; Sapsford RN; Streets EM
    J Thorac Cardiovasc Surg; 1993 Jan; 105(1):147-52; discussion 153. PubMed ID: 7678314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose aprotinin infusion is not clinically useful to reduce bleeding and transfusion of homologous blood products in high-risk cardiac surgical patients.
    Hardy JF; Desroches J; Belisle S; Perrault J; Carrier M; Robitaille D
    Can J Anaesth; 1993 Jul; 40(7):625-31. PubMed ID: 7691426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of high doses of aprotinin in cardiac surgery].
    Carrera A; Martínez MV; García-Guiral M; Herrero E; Peral A; Planas A
    Rev Esp Anestesiol Reanim; 1994; 41(1):13-9. PubMed ID: 7517058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial.
    Alderman EL; Levy JH; Rich JB; Nili M; Vidne B; Schaff H; Uretzky G; Pettersson G; Thiis JJ; Hantler CB; Chaitman B; Nadel A
    J Thorac Cardiovasc Surg; 1998 Nov; 116(5):716-30. PubMed ID: 9806378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.